Study guide
BCOP study guide
Read a lesson, then practice the ideas you want to remember.
Lessons
- BCOP Exam Specifications, Passing Standard &
- The Clinical Oncology Pharmacist Scope of Pr
- Study Guide Methodology & Active Learning St
- Early-Stage & Locoregional Breast Cancer
- Advanced & Metastatic Breast Cancer Targeted
- Epithelial Ovarian, Endometrial & Cervical M
- Cell Cycle Checkpoints, Apoptotic Pathways &
- Hallmarks of Cancer, Multi-Step Carcinogenes
- Tumor Immunology, Antigen Presentation & Mec
- Regimen Standardization, Dose Calculation Fo
- Independent Double-Check, Verification Check
- Oral Chemotherapy Management, Adherence & Sp
- Oncology Clinical Trial Designs, Endpoints &
- Evidence Synthesis, Guideline Hierarchy & Cr
- Biostatistical Concepts: Hazard Ratios, Surv
- Alkylating Agents & Platinum Analogs — Free Study Guide 2026
- Antimetabolites & Folate Antagonists — Free Study Guide 2026
- Antimicrotubule Agents: Taxanes, Vinca Alkal
- Topoisomerase Inhibitors, Anthracyclines & C
- Cancer Screening, Early Detection & Preventi
- Performance Status Scales & Organ Function A
- TNM Staging Systems, Histopathologic Grading
- Circulating Tumor Markers, Flow Cytometry &
- Actionable Oncogenic Driver Mutations & Targ
- Pharmacogenomics in Oncology: DPYD, TPMT, NU
- Somatic vs Germline Mutations, NGS Profiling
- Colorectal Cancer: Staging, Adjuvant Therapy
- Esophagogastric, Pancreatic, and Hepatobilia
- Genitourinary Malignancies: Prostate, Renal
- Engineering Controls, Personal Protective Eq
- Safe Handling, Surface Decontamination & Acc
- USP <800> & NIOSH Hazardous Drug Standards
- Complementary, Alternative & Integrative The
- Oncology Formulary Management, Biosimilars &
- Patient & Caregiver Counseling, Survivorship
- Regulatory Mandates, REMS Programs & Investi
- Chimeric Antigen Receptor T-Cell Therapies &
- Immune Checkpoint Inhibitors & irAE Manageme
- Naked Monoclonal Antibodies, Antibody-Drug C
- Acute Myeloid & Acute Lymphoblastic Leukemia
- Chronic Leukemias & Myeloproliferative Neopl
- Multiple Myeloma & Plasma Cell Dyscrasias
- Non-Malignant Hematologic Disorders: ITP, Ap
- Hematopoietic Stem Cell Transplantation, Com
- Classical Hodgkin Lymphoma: Staging, Frontli
- Non-Hodgkin Lymphomas: Aggressive, Indolent,
- Chemotherapy-Induced Nausea and Vomiting Pro
- Chemotherapy Extravasation, Organ Protectant
- Myelosuppression, Febrile Neutropenia & Grow
- Oncologic Emergencies: TLS, Hypercalcemia, S
- Hematologic Small-Molecule Kinase Inhibitors
- Pathway-Specific Inhibitors: PARP, CDK4/6, B
- Small-Molecule Tyrosine Kinase Inhibitors in
- Cutaneous Melanoma & Non-Melanoma Skin Cance
- Early & Locally Advanced NSCLC & Small Cell
- Metastatic Non-Small Cell Lung Cancer — Free Study Guide 2026